Title: Gonadotropin Receptor Cross-Talk and Altered Functions in Gonadal and Non-Gonadal Tissues
Authors: Rita Singh, Anjali Pathak
Section: 7. References
its association with cardiometabolic risk factors, and 10-year risk of cardiovascular disease in postmenopausal women. J Am Heart Assoc. 2017; 6(9). https://doi.org/10.1161/ JAHA.117.005918 44. Chin KY. The relationship between follicle-stimulating hormone and bone health: alternative explanation for bone loss beyond oestrogen? Int J Med Sci. 2018; 15(12):1373-83. https://doi.org/10.7150/ijms.26571 45. Feng Y, Zhu S, Antaris AL, Chen H, Xiao Y, Lu X, et al. Live imaging of follicle stimulating hormone receptors in gonads and bones using near Infrared II fluorophore. Chem Sci. 2017; 8(5):3703-11. https://doi.org/10.1039/ C6SC04897H 46. Liu XM, Chan HC, Ding GL, Cai J, Song Y, Wang TT, et al. FSH regulates fat accumulation and redistribution in aging through the Gαi/Ca2+/CREB pathway. Aging Cell. 2015; 14(3):409-20. https://doi.org/10.1111/acel.12331 47. Planeix F, Siraj MA, Bidard FC, Robin B, Pichon C, Sastre-Garau X, et al. Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery. J Exp Clin Cancer Res. 2015; 34(1). https://doi.org/10.1186/ s13046-015-0128-7 48. Radu A, Pichon C, Camparo P, Antoine M, Allory Y, Couvelard A, et al. Expression of Follicle-Stimulating Hormone Receptor in tumor blood vessels. N Engl J Med. 2010; 363(17):1621-30. https://doi.org/10.1056/ NEJMoa1001283 49. Pawlikowski M, Winczyk K, Stepień H. Immunohistochemical detection of Follicle Stimulating Hormone Receptor (FSHR) in neuroendocrine tumours. Endokrynol Pol. 2013; 64(4):268-71. https:// doi.org/10.5603/EP.2013.0004 Vol 27 (3) | September 2023 | http://www.informaticsjournals.com/index.php/jer/index J Endocrinol Reprod. 177 50. Pawlikowski M, Radek M, Jaranowska M, Kunert-Radek J, Swietoslawski J, Winczyk K. Expression of Follicle Stimulating Hormone Receptors in pituitary adenomas - A marker of tumour aggressiveness? Endokrynol Pol. 2014; 65(6):469-71. https://doi.org/10.5603/ EP.2014.0065 51. Pawlikowski M, Jaranowska M, Pisarek H, Kubiak R, Fuss-Chmielewska J, Winczyk K. Ectopic expression of Follicle-Stimulating Hormone Receptors in thyroid tumors. Archives of Medical Science. 2015; 11(6):1314- 17. https://doi.org/10.5114/aoms.2015.56357 52. Kero J, Poutanen M, Zhang FP, Rahman N, McNicol AM, Nilson JH, et al. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J Clin Invest. 2000; 105(5):633-41. https://doi.org/10.1172/JCI7716 53. Pabon JE, Li X, Lei ZM, Sanfilippo JS, Yussman MA, Rao CV. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J Clin Endocrinol Metab. 1996; 81(6):2397-400. https://doi. org/10.1210/jcem.81.6.8964884 54. Li S, Yang C, Fan J, Yao Y, Lv X, Guo Y, et al. Pregnancyinduced Cushing’s syndrome with an adrenocortical adenoma overexpressing LH/hCG receptors: A case report. BMC Endocr Disord. 2020; 20(1). https://doi. org/10.1186/s12902-020-0539-0 55. Plöckinger U, Chrusciel M, Doroszko M, Saeger W, Blankenstein O, Weizsäcker K, et al. Functional impli- cations of LH/hCG receptors in pregnancy-induced cushing syndrome. J Endocr Soc. 2017;